1. Home
  2. CELU vs MYND Comparison

CELU vs MYND Comparison

Compare CELU & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • MYND
  • Stock Information
  • Founded
  • CELU 2016
  • MYND 1998
  • Country
  • CELU United States
  • MYND United States
  • Employees
  • CELU N/A
  • MYND N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • MYND Other Consumer Services
  • Sector
  • CELU Health Care
  • MYND Real Estate
  • Exchange
  • CELU Nasdaq
  • MYND Nasdaq
  • Market Cap
  • CELU 42.2M
  • MYND 36.2M
  • IPO Year
  • CELU N/A
  • MYND 2017
  • Fundamental
  • Price
  • CELU $3.24
  • MYND $0.66
  • Analyst Decision
  • CELU
  • MYND
  • Analyst Count
  • CELU 0
  • MYND 0
  • Target Price
  • CELU N/A
  • MYND N/A
  • AVG Volume (30 Days)
  • CELU 586.5K
  • MYND 28.0K
  • Earning Date
  • CELU 05-08-2025
  • MYND 08-28-2025
  • Dividend Yield
  • CELU N/A
  • MYND N/A
  • EPS Growth
  • CELU N/A
  • MYND N/A
  • EPS
  • CELU N/A
  • MYND N/A
  • Revenue
  • CELU $54,220,000.00
  • MYND $267,380,999.00
  • Revenue This Year
  • CELU $23.29
  • MYND N/A
  • Revenue Next Year
  • CELU N/A
  • MYND N/A
  • P/E Ratio
  • CELU N/A
  • MYND N/A
  • Revenue Growth
  • CELU 138.11
  • MYND N/A
  • 52 Week Low
  • CELU $1.00
  • MYND $0.61
  • 52 Week High
  • CELU $5.22
  • MYND $3.89
  • Technical
  • Relative Strength Index (RSI)
  • CELU 59.84
  • MYND 34.66
  • Support Level
  • CELU $3.16
  • MYND $0.62
  • Resistance Level
  • CELU $3.40
  • MYND $0.80
  • Average True Range (ATR)
  • CELU 0.34
  • MYND 0.08
  • MACD
  • CELU -0.03
  • MYND -0.01
  • Stochastic Oscillator
  • CELU 20.71
  • MYND 11.08

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

Share on Social Networks: